← Back to Search

Polymeric Surfactant Technology Cleanser

Non-marketed Cosmetic Facial Cleanser for Atopic Dermatitis

N/A
Waitlist Available
Led By Zoe Diana Draelos, MD
Research Sponsored by Johnson & Johnson Consumer Inc. (J&JCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 2 and week 4
Awards & highlights

Summary

The purpose of this study is to evaluate the efficacy and tolerance of a gentle facial cleanser in participants with sensitive skin (eczema/atopic dermatitis, rosacea, acne, cosmetic intolerance syndrome).

Eligible Conditions
  • Atopic Dermatitis
  • Rosacea
  • Acne
  • Sensitive Skin

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 2 and week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 2 and week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mildness of the Facial Cleanser in Participants with Sensitive Skin Based on Investigator and Participant Assessments
Secondary study objectives
Investigator Assessment for Efficacy
Investigator Assessment for Tolerability
Non-invasive Assessment: Biomarker Tapes
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Non-marketed Cosmetic Facial CleanserExperimental Treatment1 Intervention
Participants will receive non-marketed cosmetic facial cleanser to apply on cleanse facial skin, twice daily for 4 weeks.

Find a Location

Who is running the clinical trial?

Johnson & Johnson Consumer Inc. (J&JCI)Lead Sponsor
52 Previous Clinical Trials
5,418 Total Patients Enrolled
Zoe Diana Draelos, MDPrincipal InvestigatorDermatology Consulting Services, PLLC
1 Previous Clinical Trials
31 Total Patients Enrolled
~22 spots leftby Sep 2025